SB1518 (pacritinib)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SB1518 (pacritinib), covering 2012-04-20 to 2012-04-20. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1/2 Study of Oral SB1518 in Subjects With Chronic Idiopathic Myelofibrosis [Phase 1, Phase 2]